Answers are grounded in this paper and cite their sources.
Evaluates a low-energy method for producing sulfuric acid from phosphogypsum, suggesting a sustainable alternative.
Sulfuric acid is the highest-tonnage industrial chemical in the world (~260 million t/year), and its feedstock base is structurally fragile: more than 90% of elemental sulfur is recovered as an involuntary byproduct of oil refining and natural-gas processing, with roughly half of seaborne sulfur trade originating in the Persian Gulf. The 2026 Strait of Hormuz disruption, which drove the Tampa quarterly sulfur contract to a record $705 per long ton — a 15-fold increase over the 2024 average — exposed this fragility, confirming earlier academic projections of a structural sulfur deficit of 100–320 million t/year by 2040 under decarbonization scenarios. Meanwhile, the United States has accumulated approximately 1.5 billion t of phosphogypsum (CaSO4·2H2O, 18.6% sulfur by mass) in surface stacks, stoichiometrically equivalent to up to 855 million t of sulfuric acid, or about 32 years of national consumption. Historical thermal routes for converting calcium sulfate to sulfuric acid (Müller-Kühne) failed economically due to energy demand of ~7.45 GJ/t at 1,100–1,400°C. This paper describes Arbok-SA, a two-stage route combining acid-medium dissolution of solid phosphogypsum with low-temperature vacuum separation (0.1–1 kPa, ambient temperature, 2–4 kWh/t), reports a measured product balance obtained on industrial phosphate-plant brine (70.0% water, 18.5% H2SO4, 7.8% HF, 2.5% H3PO4, 0.2% solids), including radionuclide extraction into an immobilized fraction of 0.1–0.5% of feed volume, and presents an economic assessment of deployment at site and national scale.
No takes yet. Share an insight, caveat, or question.
Vischmidt et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: